Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA: Oxaliplatin and Cetuximab in First-Line Treatment of Metastatic Colorectal Cancer
2005-005154-44Phase 2Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in colorectal cancer (CRC), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Best overall confirmed tumor response. Started Nov 2005; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2005-005154-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005154-44.